XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 164,595 $ 177,150
Trade accounts receivable, net of allowances of $492 and $391 at March 31, 2022 and December 31, 2021, respectively 81,121 79,143
Income taxes receivable 287 608
Deferred contract costs 14,142 12,904
Prepaid expenses 19,616 17,581
Other current assets 4,318 4,212
Total current assets 284,079 291,598
Equipment and leasehold improvements, net 18,237 18,045
Goodwill 841,984 845,734
Other intangible assets, net 251,072 264,593
Deferred contract costs, non-current 31,793 29,842
Other assets 39,159 30,608
Total assets 1,466,324 1,480,420
Current liabilities:    
Accounts payable 8,808 9,306
Accrued liabilities 45,558 54,022
Income taxes payable 376 167
Deferred revenues 234,389 223,031
Total current liabilities 289,131 286,526
Deferred revenues, non-current 58,110 59,097
Deferred tax liability, net 8,097 8,700
Convertible senior notes, net 362,648 362,031
Other liabilities 26,417 25,640
Total liabilities 744,403 741,994
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value, 50,000,000 shares authorized at March 31, 2022 and December 31, 2021; no shares issued and outstanding at March 31, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value, 500,000,000 shares authorized at March 31, 2022 and December 31, 2021; 119,659,455 and 119,426,064 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 119 119
Additional paid‑in capital 930,788 913,581
Accumulated other comprehensive loss (15,949) (7,866)
Accumulated deficit (193,037) (167,408)
Total stockholders’ equity 721,921 738,426
Total liabilities and stockholders’ equity $ 1,466,324 $ 1,480,420